Cargando…
Alemtuzumab for the treatment of multiple sclerosis
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386803/ https://www.ncbi.nlm.nih.gov/pubmed/25848299 http://dx.doi.org/10.2147/TCRM.S80112 |
_version_ | 1782365212629794816 |
---|---|
author | Willis, Mark D Robertson, Neil P |
author_facet | Willis, Mark D Robertson, Neil P |
author_sort | Willis, Mark D |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4386803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43868032015-04-06 Alemtuzumab for the treatment of multiple sclerosis Willis, Mark D Robertson, Neil P Ther Clin Risk Manag Review Dove Medical Press 2015-03-31 /pmc/articles/PMC4386803/ /pubmed/25848299 http://dx.doi.org/10.2147/TCRM.S80112 Text en © 2015 Willis et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Willis, Mark D Robertson, Neil P Alemtuzumab for the treatment of multiple sclerosis |
title | Alemtuzumab for the treatment of multiple sclerosis |
title_full | Alemtuzumab for the treatment of multiple sclerosis |
title_fullStr | Alemtuzumab for the treatment of multiple sclerosis |
title_full_unstemmed | Alemtuzumab for the treatment of multiple sclerosis |
title_short | Alemtuzumab for the treatment of multiple sclerosis |
title_sort | alemtuzumab for the treatment of multiple sclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386803/ https://www.ncbi.nlm.nih.gov/pubmed/25848299 http://dx.doi.org/10.2147/TCRM.S80112 |
work_keys_str_mv | AT willismarkd alemtuzumabforthetreatmentofmultiplesclerosis AT robertsonneilp alemtuzumabforthetreatmentofmultiplesclerosis |